Steffen Schulze F. Hoffmann-La Roche

Steffen Schulze is the Strategic Analytics & Business Insights Lead in Roche's Cell & Gene Therapies division, specializing in quantitative modeling to assess and integrate data from preclinical stages to product commercialization in the ATMP field. With a background in preclinical research, including antibody identification and process development, Steffen gained technical expertise in commercial manufacturing as a quality assurance specialist and GMP project manager. Within Roche, he contributed to cost assessments for a personalized cancer vaccine and an autologous gene therapy, as well as preparing the drug product sourcing strategy for an antibody drug conjugate. Steffen's multidisciplinary expertise bridges scientific, technical, and economic aspects, supporting Roche's advancements in the cell and gene therapy field.